共 204 条
[1]
Cuerda C(2021)ESPEN practical guideline: clinical nutrition in chronic intestinal failure Clin Nutr 40 5196-5220
[2]
Pironi L(2007)Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease J Perinatol 27 284-290
[3]
Arends J(2021)Impact of parenteral lipid emulsion components on cholestatic liver disease in neonates Nutrients 13 508-37
[4]
Bozzetti F(2010)High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis JPEN J Parenter Enternal Nutr 34 32-214
[5]
Gillanders L(2012)Intestinal failure-associated liver disease in hospitalised children Arch Dis Child 97 211-1326
[6]
Jeppesen PB(2018)Pediatric intestinal failure review Children (Basel) 5 100-744
[7]
Christensen RD(2017)Parenteral nutrition-associated liver disease: the role of the gut microbiota Nutrients 9 987-1273
[8]
Henry E(2017)Alterations in intestinal microbiota relate to intestinal failure-associated liver disease and central line infections J Pediatr Surg 52 1318-219
[9]
Wiedmeier SE(2021)Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver disease J Pediatr Surg 56 738-1542
[10]
Burnett J(2012)Interactions between the microbiota and the immune system Science 336 1268-1205